SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-165187
Filing Date
2020-06-10
Accepted
2020-06-10 08:50:34
Documents
6
Period of Report
2020-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d939171d8k.htm 8-K 37910
2 EX-2.1 d939171dex21.htm EX-2.1 548128
3 EX-10.1 d939171dex101.htm EX-10.1 26674
4 EX-10.2 d939171dex102.htm EX-10.2 26711
5 EX-99.1 d939171dex991.htm EX-99.1 33242
6 GRAPHIC g939171g0609184151895.jpg GRAPHIC 4946
  Complete submission text file 0001193125-20-165187.txt   680894
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 20953607
SIC: 2834 Pharmaceutical Preparations